Internal Medicine, Endocrinology, Diabetes, & Metabolism · Miami, FL
NPI
1194173831
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
12515 SW 88th St
Miami, FL, 33186
Phone (305) 642-5366
Groups this clinician bills Medicare through
Medicare paid, 2022
$7,866
74 services
Medicare patients, 2022
39
Average age 70
Drug cost, 2024
$3.0M
14,628 prescriptions
Company payments, 2025
$59.06
From 3 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Daniela M Dicenso was code 99214 (office e&m - established), 41 times for 32 patients. In total Daniela M Dicenso billed 74 services in 11 codes, and Medicare paid $7,866.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 41 | 32 | $106.07 | $4,349 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniela M Dicenso prescribed most often to Medicare patients was Glipizide Er (Glipizide), with 1,710 prescriptions and refills. In total Daniela M Dicenso wrote 14,628 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Glipizide Er Glipizide | 1,710 | 3,817 | 470 | $14K |
| Glipizide Generic | 1,047 | 2,345 | 291 | $3,834 |
| Dapagliflozin Dapagliflozin Propanediol | 1,018 | 1,356 | 243 | $389K |
| Dapagliflozin-Metformin Er Dapaglifloz Propaned/Metformin | 846 | 1,152 | 186 | $342K |
| Levothyroxine Sodium Generic | 690 | 1,594 | 238 | $2,009 |
| Insulin Glargine-Yfgn Generic | 649 | 678 | 126 | $39K |
| Glipizide-Metformin Glipizide/Metformin Hcl | 519 | 1,080 | 152 | $9,948 |
| Ozempic Semaglutide | 477 | 699 | 123 | $500K |
| Synjardy Empagliflozin/Metformin Hcl | 390 | 575 | 109 | $195K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 384 | 565 | 77 | $245K |
| Insulin Glargine Solostar Insulin Glargine,hum.Rec.Anlog | 358 | 393 | 91 | $63K |
| Testosterone Cypionate Generic | 345 | 347 | 33 | $8,972 |
| Testosterone Generic | 333 | 339 | 63 | $16K |
| Synthroid Levothyroxine Sodium | 326 | 646 | 85 | $32K |
| Comfort Ez Pen Needle Pen Needle, Diabetic | 269 | 336 | 125 | $2,625 |
Brand drugs: 7,640 claims; generic drugs: 6,674 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniela M Dicenso $59.06 ($59.06 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $24.2.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.